Medopad, a London-based mobile platform for healthcare companies, insurers, doctors and patients, is working with Bayer AG to raise $30m from private investors. The new funds will be used to expand Medopad’s analytics and machine learning teams. Medopad already has support from UBS Group and has expanded into Germany and the US.
Medopad, a London-based mobile platform for healthcare companies, insurers, doctors and patients, is working with UBS Group to raise $30m from private investors. The new funds will be used to expand Medopad’s analytics and machine learning teams. Medopad already has support from Bayer AG and has expanded into Germany and the US.